Terry Derks

Dr. Terry Derks is an Associate Professor and Consultant Pediatric Metabolic Diseases specialist at the University of Groningen's Faculty of Medical Sciences. He holds leadership roles including Principal Investigator at UMCG's MoHAD Research Institute and Board Member of the European Reference Network for Hereditary Metabolic Diseases (MetabERN). His expertise focuses on inborn errors of metabolism, neonatal screening, and glycogen storage diseases (GSD).

Education: MSc Medicine (1999), MD (2001), Pediatrics Specialization (2010), Inborn Errors of Metabolism Specialization (2013), PhD (2007) on MCAD deficiency.

Research Interests: Dr. Derks leads research on metabolic disorders such as GSD, MCADD, and MADD. Key areas include diagnostic methodologies (e.g., machine learning models), therapy development (e.g., gene therapy), and international consensus-building for disease management. His work emphasizes clinical trials, newborn screening optimization, and patient-centered care innovations.

Awards: Recognized with the Garrod Award (2017), Mandema Stipend (2009), and Beatrix Children's Hospital Teaching Prize (2022).

Grants & Labs: Oversees projects funded by grants like CNPq and collaborates internationally. Coordinates initiatives like GSD Value and the International GSD Priority Setting Partnership. Active in teaching at undergraduate and postgraduate levels, including summer schools and mentorship programs.

Labs/Teams: Leads metabolic disease research teams at Beatrix Children's Hospital and UMCG, focusing on interdisciplinary collaborations between clinicians, biochemists, and geneticists.